Effects of whole body vibration in the elderly and in neurologic disorders

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

DRKS

Registry ID

DRKS00012265

Enrollment

200

Registered

2017-04-04

Start date

2017-04-20

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease Multiple Sclerosis, Apoplex G20 G35 I63

Interventions

Group 1: Whole body vibration

different frequencies for treatment groups (6, 12, 18, and 24 Hz), times per week (1, 2, 3, or 4x/week), duration at least 4 weeks up to 1 year Group 2: Placebo group: same setting as treatment group,

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Parkinson's Disease (confirmed), Multiple Sclerosis or Apoplex, no matter what duration and severity/stage of the disease; elderly who cannot participate on conventional physical training

Exclusion criteria

Exclusion criteria: severe coronary heart disease, acute thrombosis, fracture, or knee or hip prosthesis (for less than 3 months), severe diabetes, arrhythmia, pacemaker, untreated hypertonia, open wounds on the soles

Design outcomes

Primary

Measure	Time frame
Improvement after treatment over a few weeks for balance (Force plate: Sway path, and velocity, body position; Berg Balance Scale), mobility (Timed up and Go), flexibility (Sit and reach),... Measurement before first treatment and 20 minutes after last treatment (after 4, 8, or 12 weeks), then follow-up after 1, 2, and 4 weeks	—

Countries

Germany

Contacts

Public ContactAndrea Dincher

Sportwissenschaftliches Institut der Universität des Saarlandes

andrea.dincher@uni-saarland.de06813022534

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026